A detailed history of Northwest Financial Advisors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Northwest Financial Advisors holds 65 shares of BMY stock, worth $3,784. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65
Previous 65 -0.0%
Holding current value
$3,784
Previous $2.7 Million 24.6%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$40.25 - $52.99 $37,150 - $48,909
-923 Reduced 93.42%
65 $2.7 Million
Q1 2024

May 09, 2024

BUY
$47.98 - $54.4 $22,310 - $25,296
465 Added 88.91%
988 $53.6 Million
Q4 2023

Feb 07, 2024

BUY
$48.48 - $57.85 $25,355 - $30,255
523 New
523 $26.8 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Northwest Financial Advisors Portfolio

Follow Northwest Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Financial Advisors with notifications on news.